Proscia is fighting cancer with intelligent software that changes the way the world practices pathology. Cancer research and diagnosis are being redefined by a new kind of lab: those that are realizing the promise of artificial intelligence to elevate the pathologist’s role in an era of increasingly personalized medicine and streamline operations to drive unprecedented results. Proscia is pushing labs past the limits of traditional tools with its Concentriq® digital pathology platform and pipeline of computational applications. Operating at the center of the modern digital laboratory, these technologies are transforming the economics and practice of pathology, putting the power of modern, data-centric medicine to work in the fight against cancer.

Concentriq is designed for research and clinical workflows. Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes. We’re helping labs and research centers take advantage of the collaboration, insight, accuracy, and time-saving benefits of digital pathology, and accelerating breakthroughs in the fight against cancer. Learn more about our vision for powering this new era of data-driven pathology.